Target intelligence / Profile preview

Membrane lipid bilayer

Molecular classification
Other, Lipid structure
01

Overview

The membrane lipid bilayer is a fundamental biological structure composed of two layers of amphipathic phospholipids that forms the primary barrier of cells and organelles (StatPearls, 2023). Beyond its structural role, the bilayer serves as a dynamic platform for signal transduction, protein recruitment, and cellular communication (Nature Reviews Molecular Cell Biology, 2008). In various diseases, such as cancer and neurodegeneration, the lipid composition and physical properties of the membrane are significantly altered, affecting the function of embedded proteins (Journal of Cellular and Molecular Medicine, 2015). Therapeutic intervention, known as Membrane Lipid Therapy (MLT), involves using molecules to modify these lipid environments to restore normal signaling or selectively destroy pathogens (Trends in Molecular Medicine, 2017). For example, certain antibiotics like Polymyxin B and antifungals like Amphotericin B disrupt the integrity of microbial membranes to induce cell death (Clinical Microbiology Reviews, 2017). Novel synthetic lipids, such as 2-hydroxyoleic acid, are also being developed to regulate oncogenic signaling pathways by altering membrane fluidity and organization (British Journal of Cancer, 2011).

Other names
Phospholipid bilayerCell membranePlasma membraneLipid membraneBiological membrane
02

Mechanism of action

Drugs targeting the membrane lipid bilayer typically act by altering membrane physical properties such as fluidity and thickness, forming transmembrane pores to induce leakage of cellular contents, or modulating the recruitment and activity of membrane-bound signaling proteins through changes in lipid composition (Journal of Cellular and Molecular Medicine, 2015; Nature Reviews Drug Discovery, 2008).

03

Biological functions

Barrier functionSignal transductionCompartmentalizationCellular homeostasisVesicular transport
04

Disease associations

CancerNeurodegenerative diseaseInfectionCardiovascular diseaseMetabolic disorder
05

Safety considerations

Non-specific cytotoxicityHemolysisNephrotoxicityNeurotoxicityNarrow therapeutic index
06

Interacting drugs

Amphotericin B

7 more in the full profile.

07

Biomarkers

Lipidomic profileMembrane fluidityPhospholipid compositionCholesterol levels

Beyond the preview

Go deeper on Membrane lipid bilayer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Membrane lipid bilayer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call